Table 4. Hazard ratios for... | American Society of Hematology

Table 4.

Hazard ratios for progression-free survival and overall survival within genotypic groups for patients treated with CVAMP/HDM compared with ABCM

	Progression-free survival			Overall survival
Genotype	Adjusted hazard ratio^*†	95% CI	Adjusted hazard ratio^*†	95% CI
Ile/Ile	0.29	0.18-0.49	0.40	0.23-0.72
Ile/Val	0.76	0.43-1.40	1.00	0.52-1.95
Val/Val	0.64	0.25-1.63	0.67	0.20-2.16

	Progression-free survival			Overall survival
Genotype	Adjusted hazard ratio^*†	95% CI	Adjusted hazard ratio^*†	95% CI
Ile/Ile	0.29	0.18-0.49	0.40	0.23-0.72
Ile/Val	0.76	0.43-1.40	1.00	0.52-1.95
Val/Val	0.64	0.25-1.63	0.67	0.20-2.16

Hazard ratios are for PFS and OS comparing outcome following CVAMP/HDM with ABCM and are adjusted for age, sex, and levels of hemoglobin, creatinine, and B₂M.

†

P = .008.

‡

P = .064.

View Large

This Feature Is Available To Subscribers Only